Use of L-carnitine for the treatment of cardiovascular diseases
    1.
    发明授权
    Use of L-carnitine for the treatment of cardiovascular diseases 有权
    使用左旋肉碱治疗心血管疾病

    公开(公告)号:US08394854B2

    公开(公告)日:2013-03-12

    申请号:US12972617

    申请日:2010-12-20

    申请人: Aleardo Koverech

    发明人: Aleardo Koverech

    IPC分类号: A61K31/205 A61P9/10

    摘要: The use of L-carnitine, or one of its pharmaceutically acceptable salts, is described in combination with glucose for the preparation of a medicament useful for diminishing the number of deaths caused by acute myocardial infarction, for reducing the number of days infarction patients spend in intensive care in hospital, and for reducing the number of episodes of post-infarction heart failure, in which the L-carnitine is administered intravenously within only a few hours of the onset of symptoms of acute myocardial infarction at an initial dose of 9 grams a day in combination with 1000-1500 mL of a 5% glucose solution for 5 days, after which the L-carnitine treatment is continued at a dose of 4 grams a day administered orally.

    摘要翻译: 联合使用左旋肉碱或其药学上可接受的盐之一与葡萄糖联合用于制备用于减少由急性心肌梗塞引起的死亡人数的药物,以减少患者花费的时间 在医院进行重症监护,并减少梗死后心力衰竭的发作次数,其中在起始剂量为9克a的急性心肌梗死症状发作几小时内,左旋肉碱静脉注射 天与1000-1500mL的5%葡萄糖溶液组合5天,之后以每天4克的剂量持续口服左旋肉碱治疗。